Drugs / rLukS-PV
last change Mar 2011 re-read 3 minutes ago

rLukS-PV

Developed for
staphylococcus aureus infection
Investigated by
Henry M. Jackson Foundation for the Advancement of Military Medicine · Nabi Biopharmaceuticals

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01011335 Nov 2009 → Mar 2011 staphylococcus aureus infection Henry M. Jackson Foundation for the Advancement of Military Medicine Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as rLukS-PV ClinicalTrials.gov intervention name — accepted as the source's own label NCT01011335 ↗